209 related articles for article (PubMed ID: 27373655)
1. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of ecteinascidins. Part 4: preparation of 2'-N-acyl ecteinascidin 770 derivatives with improved cytotoxicity profiles.
Tsujimoto M; Lowtangkitcharoen W; Mori N; Pangkruang W; Putongking P; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2013; 61(10):1052-64. PubMed ID: 24088697
[TBL] [Abstract][Full Text] [Related]
4. Chemistry of ecteinascidins. Part 2. Preparation of 6'-O-acyl derivatives of stable ecteinascidin and evaluation of cytotoxicity.
Puthongking P; Patarapanich C; Amnuoypol S; Suwanborirux K; Kubo A; Saito N
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1010-6. PubMed ID: 16819221
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs.
Liu ZZ; Wang Y; Tang YF; Chen SZ; Chen XG; Li HY
Bioorg Med Chem Lett; 2006 Mar; 16(5):1282-5. PubMed ID: 16338237
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.
Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L
Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines.
Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P
ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364
[TBL] [Abstract][Full Text] [Related]
10. Discovery of N-substituted 3-arylisoquinolone derivatives as antitumor agents originating from O-substituted 3-arylisoquinolines via [2,3] or [3,3] rearrangement.
Li B; Wang G; Xu Z; Zhang Y; Huang X; Zeng B; Chen K; Shi J; Wang H; Zhu W
Eur J Med Chem; 2014 Apr; 77():204-10. PubMed ID: 24637214
[TBL] [Abstract][Full Text] [Related]
11. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa.
Guo J; Dong W; Liu W; Yan Z; Wang N; Liu Z
Eur J Med Chem; 2013 Apr; 62():670-6. PubMed ID: 23434640
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents].
Wang YX; Zhao WL; Bi CW; Li YB; Shao RG; Song DQ
Yao Xue Xue Bao; 2012 Feb; 47(2):200-5. PubMed ID: 22512031
[TBL] [Abstract][Full Text] [Related]
15. Mild C(sp
Romo-Pérez A; Miranda LD; Chávez-Blanco AD; Dueñas-González A; Camacho-Corona MDR; Acosta-Huerta A; García A
Eur J Med Chem; 2017 Sep; 138():1-12. PubMed ID: 28641156
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L
Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues.
Nieto-García O; Alonso R
Org Biomol Chem; 2013 Jan; 11(3):515-22. PubMed ID: 23207545
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, cytotoxicities and DNA cleavage activities of dibenzoxepine and isoquinoline derivatives starting from dehydroabietylamine.
Liu CX; Lin ZX; Zhou AM
J Asian Nat Prod Res; 2016 Dec; 18(12):1169-1177. PubMed ID: 27696913
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells.
Di Salvo A; Dugois P; Tandeo D; Peltekian M; Kong Thoo Lin P
Eur J Med Chem; 2013 Nov; 69():754-61. PubMed ID: 24099994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]